Literature DB >> 21084112

Ebola haemorrhagic fever.

Heinz Feldmann1, Thomas W Geisbert.   

Abstract

Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man, designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The exception is the species Reston Ebola virus, which has not been associated with human disease and is found in the Philippines. Ebola virus constitutes an important local public health threat in Africa, with a worldwide effect through imported infections and through the fear of misuse for biological terrorism. Ebola virus is thought to also have a detrimental effect on the great ape population in Africa. Case-fatality rates of the African species in man are as high as 90%, with no prophylaxis or treatment available. Ebola virus infections are characterised by immune suppression and a systemic inflammatory response that causes impairment of the vascular, coagulation, and immune systems, leading to multiorgan failure and shock, and thus, in some ways, resembling septic shock.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21084112      PMCID: PMC3406178          DOI: 10.1016/S0140-6736(10)60667-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  124 in total

1.  Field investigations of an outbreak of Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: arthropod studies.

Authors:  P Reiter; M Turell; R Coleman; B Miller; G Maupin; J Liz; A Kuehne; J Barth; J Geisbert; D Dohm; J Glick; J Pecor; R Robbins; P Jahrling; C Peters; T Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

2.  Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  S F Dowell; R Mukunu; T G Ksiazek; A S Khan; P E Rollin; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

3.  Ecology of Marburg and Ebola viruses: speculations and directions for future research.

Authors:  T P Monath
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

4.  A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams.

Authors:  J G Breman; K M Johnson; G van der Groen; C B Robbins; M V Szczeniowski; K Ruti; P A Webb; F Meier; D L Heymann
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  A S Khan; F K Tshioko; D L Heymann; B Le Guenno; P Nabeth; B Kerstiëns; Y Fleerackers; P H Kilmarx; G R Rodier; O Nkuku; P E Rollin; A Sanchez; S R Zaki; R Swanepoel; O Tomori; S T Nichol; C J Peters; J J Muyembe-Tamfum; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  L L Rodriguez; A De Roo; Y Guimard; S G Trappier; A Sanchez; D Bressler; A J Williams; A K Rowe; J Bertolli; A S Khan; T G Ksiazek; C J Peters; S T Nichol
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection.

Authors:  H Leirs; J N Mills; J W Krebs; J E Childs; D Akaibe; N Woollen; G Ludwig; C J Peters; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.

Authors:  F Villinger; P E Rollin; S S Brar; N F Chikkala; J Winter; J B Sundstrom; S R Zaki; R Swanepoel; A A Ansari; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.

Authors:  M E Miranda; T G Ksiazek; T J Retuya; A S Khan; A Sanchez; C F Fulhorst; P E Rollin; A B Calaor; D L Manalo; M C Roces; M M Dayrit; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  ELISA for the detection of antibodies to Ebola viruses.

Authors:  T G Ksiazek; C P West; P E Rollin; P B Jahrling; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

View more
  493 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Ebola virus transmission in guinea pigs.

Authors:  Gary Wong; Xiangguo Qiu; Jason S Richardson; Todd Cutts; Brad Collignon; Jason Gren; Jenna Aviles; Carissa Embury-Hyatt; Gary P Kobinger
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.

Authors:  Jin Huk Choi; Stephen C Schafer; Lihong Zhang; Gary P Kobinger; Terry Juelich; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2011-12-15       Impact factor: 4.939

4.  The Current Mental Health Status of Ebola Survivors in Western Africa.

Authors:  Sankalp Yadav; Gautam Rawal
Journal:  J Clin Diagn Res       Date:  2015-10-01

5.  Ebolavirus polymerase uses an unconventional genome replication mechanism.

Authors:  Laure R Deflubé; Tessa N Cressey; Adam J Hume; Judith Olejnik; Elaine Haddock; Friederike Feldmann; Hideki Ebihara; Rachel Fearns; Elke Mühlberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-08       Impact factor: 11.205

6.  Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.

Authors:  Alison E Heald; Patrick L Iversen; Jay B Saoud; Peter Sazani; Jay S Charleston; Tim Axtelle; Michael Wong; William B Smith; Apinya Vutikullird; Edward Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

7.  Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit.

Authors:  P S C Rees; L E M Lamb; T C Nicholson-Roberts; C N Ardley; M S Bailey; D E Hinsley; T E Fletcher; S J Dickson
Journal:  Intensive Care Med       Date:  2015-03-12       Impact factor: 17.440

8.  Spatial Determinants of Ebola Virus Disease Risk for the West African Epidemic.

Authors:  Kate Zinszer; Kathryn Morrison; Aman Verma; John S Brownstein
Journal:  PLoS Curr       Date:  2017-03-31

Review 9.  Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.

Authors:  Katharine Ker; Gavin Tansley; Deirdre Beecher; Anders Perner; Haleema Shakur; Tim Harris; Ian Roberts
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

Review 10.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.